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Abstract
Background: Diabetes mellitus (DM) is an important public health concern, the impact of which is
increased by the high prevalence of co-existing chronic medical conditions among subjects with DM. The
aims of this study were therefore to (1) evaluate the impact of DM and co-existing chronic medical
conditions on health-related quality of life (HRQoL) (which could be additive, synergistic or subtractive);
(2) to determine the extent to which the SF-6D (a single-index preference measure) captures the
multidimensional information provided by the SF-36 (a profile measure).
Methods: Using data from a cross-sectional, population-based survey of Chinese, Malay and Indians in
Singapore, we developed 9 separate multiple linear regression models, with each SF-36 scale or SF-6D
index score being the dependent variable for one model. The influence of DM and a second chronic
medical condition (hypertension (HTN), heart disease (HD), musculoskeletal illnesses (MS)) and their
interactions were studied after adjusting for the influence of potential confounding variables.
Results: Among 5,224 subjects, the prevalence of DM, HTN, HD and MS were 5.9%, 10.7%, 2.4% and
26.6% respectively. DM lowered SF-36 scores by more than 2 points on 3 SF-36 scales and lowered SF-
6D scores by 0.03 points. Subjects with DM and HTN, DM and HD or DM and MS experienced further
lowering of SF-36 scores exceeding 2 points on at least 6 scales and further lowering of SF-6D scores by
0.05, 0.08 and 0.10 points respectively. Generally, DM and co-existing medical conditions exerted additive
effects on HRQoL, with the exception of DM and heart disease, where a subtractive effect was noted. SF-
6D index scores generally reflected the patterns of influence of DM and chronic medical conditions on SF-
36 scores.
Conclusion: DM and chronic medical conditions generally reduced HRQoL in this multiethnic general
population in an additive, rather than synergistic or subtractive fashion. In this study, the SF-6D was a
reasonably good summary measure for the SF-36.
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Background
Diabetes mellitus, the prevalence of which is reaching epi-
demic proportions in many parts of the world, is an
increasingly important public health concern. In the
United States, diabetes is present in 8% of the adult pop-
ulation, and is associated with a two-fold increase in age-
adjusted mortality [1,2]. In addition, there is a high prev-
alence of chronic medical conditions among subjects with
diabetes [3-5]. For example, in the United States, the prev-
alence of cardiovascular diseases, stroke and depression in
subjects with diabetes was at least twice as high as in sub-
jects without diabetes [6-9].
Diabetes has detrimental effects on a range of health out-
comes including health-related quality of life (HRQoL)
[10-12]. For example, in the Medical Outcomes Study,
diabetes was found to impair all dimensions of health
except mental health and pain [13]. In a more recent mul-
tinational study, diabetes was found to have a notable
impact on general health, measured using the Medical
Outcomes Short-Form 36 (SF-36) [14]. The magnitude of
impact of diabetes on HRQoL was reported to be equiva-
lent to that of having cardiovascular conditions, cancer
and chronic respiratory disease [15].
Subjects with diabetes and multiple co-existing chronic
medical conditions have poorer HRQoL than those with-
out these conditions [16,17]. For example, subjects with
diabetes and co-existing cardiovascular diseases reported
significantly lower scores on RAND-36 social functioning,
vitality and health-change scales [16]. In another study,
subjects with diabetes and co-existing coronary artery dis-
ease, peripheral sensory neuropathy and peripheral vascu-
lar diseases reported significantly lower scores on several
SF-36 scales [17].
In combination, the influence of multiple chronic medi-
cal conditions on HRQoL may exhibit an additive, syner-
gistic or possibly subtractive relationship. Assuming that
each chronic medical condition results in the lowering of
HRQoL, in an additive relationship, the combined effect
of two or more chronic medical conditions on HRQoL
approximates the sum of the independent effect of each of
these conditions, while in a synergistic relationship, the
combined effect is greater than the sum of the independ-
ent effect of each of these conditions and in a subtractive
relationship the combined effect is smaller than the sum
of the independent effect of each of these conditions (Fig-
ure 1). For example, the SF-36 developers [18] reported an
additive relationship between hypertension and other co-
existing chronic medical conditions on HRQoL, while
Gaynes et al. [19] reported synergistic relationships
between depression and co-existing arthritis on physical
functioning and between depression and co-existing dia-
betes on role functioning. Several mechanisms could
account for these observed synergistic effects. For exam-
ple, treatment for one medical condition might also
adversely affect another pre-existing medical condition,
leading to a greater lowering of HRQoL than would occur
due to the pre-existing condition alone [20]. Additionally,
a medical condition itself (e.g. depression) might
adversely affect patient behavior and thus negatively affect
treatment outcomes [21]. Although there have not been
any reports in the literature, it is theoretically possible that
subtractive relationships exist. For example, it was
reported that patients undergo changes in their concep-
tion of poor levels of functioning, personal values (e.g.
changes in life priority) and/or meaning of life in
response to their chronic medical conditions, a concept
known as response shift [22]. These changes in self-assess-
ment and values may help to cushion the impact of the
second medical condition, resulting in a smaller decre-
ment in HRQoL than might otherwise be expected.
Two published studies have evaluated the relationship
between diabetes and other chronic medical conditions
on HRQoL in the general population [23,24]. In the first
study [23], diabetes and stroke were found to increase the
risks of disability (measured with the Activity of Daily Liv-
ing and Instrumental Activity of Daily Living scales)
among older Mexican Americans in an additive fashion.
In the second study, the impact of co-existing obesity,
hypertension or diabetes and heart disease on HRQoL
among 17,195 U.S. middle- and older-age adults was eval-
uated [24]. A strong synergistic relationship between heart
disease and diabetes on the odds of mobility difficulty
(1.8 to 4.0 times), activity of daily living limitations (2.2
to 4.0 times) and poor perceived health (2.1 to 6.8 times)
was found, after adjusting for gender, ethnicity, insurance
status, history of cancer, and lung diseases [24]. However,
there were two important limitations in both studies.
First, these studies focused on the physical domains of
HRQoL, without assessing the mental and social domains
of HRQoL. Second, both studies were conducted among
middle-aged and/or elderly adults. Thus, the burden of
diabetes and other chronic medical conditions on HRQoL
in the rest of the general population with diabetes are not
known. Further studies to elucidate the relationship
between diabetes and other chronic medical conditions
on physical, mental and social domains of HRQoL in the
general population are clearly needed.
The primary purpose of this study was therefore to evalu-
ate the impact of diabetes and co-existing chronic medical
conditions on the physical, mental and social domains of
HRQoL in the general population. We also sought to
determine if the impact of diabetes and co-existing
chronic medical conditions on HRQoL would be additive,
synergistic or subtractive. For these purposes, we meas-
ured HRQoL using both the SF-36 and the SF-6D. The SF-
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An overview of the possible relationships among multiple chronic medical conditions on HRQoLFigur  1
An overview of the possible relationships among multiple chronic medical conditions on HRQoL. *These relationships (sub-
tractive or synergistic) are discussed in relation to additive relationships. †If net effect is zero, then discussion of subtractive 
and synergistic relationships do not apply.
Possible relationships
Effects of chronic
medical condition A on 
HRQoL
Effects of chronic
medical condition B on 
HRQoL
Additive Subtractive* Synergistic*
Lowers HRQoL Lowers HRQoL Lowering of HRQoL
approximates the sum of 
the independent effects
of conditions A and B.
Lowering of HRQoL is
less than expected in an
additive relationship.
Lowering of HRQoL is
more than expected in
an additive relationship.
Improves HRQoL Improves HRQoL Improvement in HRQoL
approximates the sum of 
the independent effects
of conditions A and B.
Improvement in HRQoL
is less than expected in 
an additive relationship.
Improvement in HRQoL
is more than expected in
an additive relationship.
Lowers HRQoL Improves HRQoL Net effect†:
Lowering of HRQoL
approximates the sum of 
the independent effects
of conditions A and B.
Lowering of HRQoL is
less than expected in an
additive relationship.
Lowering of HRQoL is
more than expected in
an additive relationship.
Lowers HRQoL Improves HRQoL Net effect†: Improvement
in HRQoL approximates
the sum of the
independent effects of
conditions A and B.
Improvement in HRQoL
is less than expected in 
an additive relationship.
Improvement in HRQoL
is more than expected in
an additive relationship.
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36 is a comprehensive, generic HRQoL measure that has
been extensively validated and allows comparison of
HRQoL in subjects with various chronic medical condi-
tions. The SF-6D is a single index utility score derived
from the SF-36 which measures health preference, and
which is therefore suitable for pharmacoeconomic analy-
ses to assist healthcare resource allocation. We sought to
determine the extent to which the SF-6D would reflect the
multidimensional information provided by the SF-36.
Methods
Study design
We analyzed data from a cross-sectional, population-
based disproportionately stratified sample of ethnic Chi-
nese, Malays and Indians listed in the 1996 electoral reg-
ister for the Bishan-Toa Payoh district (representative of
the general population) in Singapore from April 1998 to
January 1999, details of which have been reported previ-
ously [25] and are summarized here. Participants com-
pleted either the UK English or Chinese (Hong Kong) SF-
36 and the Family Functioning Measure. Eligibility criteria
were: age 21 to 65 years on 1st January 1998 and ability to
read a newspaper in English or Chinese; Chinese, Malay
or Indian ethnicity as reflected in the National registration
identification card, which reflects parental ethnicity; and
status as free-living adults in the community. Persons
older than 65 years of age were excluded because of low
literacy rates in this age group in Singapore [26]. Field-
workers visited eligible subjects at their house within 7
days after an introductory letter was sent, invited them to
self-administer the SF-36, checked returned question-
naires for completeness and obtained information on eth-
nicity, socioeconomic status and chronic medical
conditions (including diabetes, hypertension, heart dis-
ease, lung diseases, musculoskeletal illnesses and mental
illnesses) and other potential determinants of HRQoL
through a structured interview. Participants were asked to
indicate either "yes" or "no" on a list of chronic medical
conditions including diabetes, high blood pressure, heart
disease, etc.
Instruments
The Short-Form 36 Health Survey (SF-36)
The SF-36 measures perceived health in the areas of phys-
ical functioning (PF), role-physical (RP), bodily pain
(BP), general health (GH), vitality (VT), social function-
ing (SF), role-emotional (RE), and mental health (MH),
with higher scores (range 0–100) reflecting better per-
ceived health. The UK English [27] and Chinese (Hong
Kong) [28] SF-36 with 4-week recall and metric units of
measurement were used in this study (previously vali-
dated for use in Singapore) [25].
The SF-6D
The SF-6D is a six-dimensional health classification sys-
tem assessing physical functioning (PF), role limitations
(RL), social functioning (SF), pain (PN), mental health
(MH), and vitality (VT), with 4 to 6 levels per dimension
[29,30]. A SF-6D "health state" is defined by selecting one
level from each dimension. For example, perfect health on
the SF-6D would be represented by the health state
111111. A total of 18,000 health states are thus defined.
All responders to the original SF-36 questionnaire can be
assigned an SF-6D score provided the items used to con-
struct the SF-6D are completed [29,30]. The SF-6D prefer-
ence-based measure can be regarded as a continuous
variable scored on a 0.29 to 1.00 scale, with 0.29 corre-
sponding to the worst health state (i.e. all dimension
being at the worst level) and 1.00 corresponding to "full
health" (i.e. all dimensions being at full functional level).
Family Functioning Measure
The Family Functioning Measure is a 3-item Likert scale
assessing the quality of interactions among family mem-
bers [31], with higher scores (range 0–100) reflecting bet-
ter family functioning, and has been validated for use in
Singapore [32].
Statistical analyses
Data from participants completing English and Chinese
SF-36 versions were pooled to increase the power and rep-
resentativeness of our study. This approach was supported
by previous work demonstrating equivalence of these SF-
36 [33] and SF-6D [34] versions in this same study sam-
ple. Data were entered into an Excel spreadsheet (Micro-
soft Corporation, Redmond, Washington) and analyzed
using SPSS (SPSS Inc., Chicago, Illinois) software. SF-6D
index scores were calculated using a utility function
derived from the United Kingdom general population
[29], which is currently the only published SF-6D scoring
algorithm. Participants with missing scale scores were
excluded listwise from analysis.
To study the influence of diabetes and other chronic med-
ical conditions on HRQoL, we developed 9 multiple lin-
ear regression models, with each SF-36 scale and the SF-
6D index score being the dependent variable for a separate
model. Each model was built in 3 stages. The first stage
assessed the effect of diabetes on HRQoL while adjusting
for the influence of sociodemographic factors. The second
stage assessed the independent effects of diabetes and a
second chronic medical condition on HRQoL while
adjusting for the influence of sociodemographic factors.
The third stage additionally assessed any interactions
between diabetes and this second chronic medical condi-
tion on HRQoL. Thus, each model studied the effect of
diabetes and one other chronic medical condition. The
absence of a significant interaction term would suggest
Health and Quality of Life Outcomes 2005, 3:2 http://www.hqlo.com/content/3/1/2
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Table 1: Characteristics of subjects and distribution of SF-36 scales and SF-6D index scores.
Subject characteristics (N = 5,224) N (%) unless specified otherwise
Mean (SD) age in years 40.3 (11.52)
Female gender 2,555 (48.9)
Ethnicity
Chinese 2,558 (49.0)
Malay 1,189 (22.8)
Indian 1,477 (28.3)
Housing type
Lower cost public housing 388 (7.4)
Public housing 4,647 (89.0)
Private housing 188 (3.6)
Years of education
≤ 6 1,266 (24.2)
7–10 2,682 (51.3)
>10 1,276 (24.4)
Marital status
Married 3,686 (70.6)
Single 1,272 (24.3)
Divorced/Separated 136 (2.6)
Widow 130 (2.5)
Working 4,022 (75.0)
Smoking 1,045 (20.0)
Presence of acute medical conditions* 3,493 (66.9)
Presence of chronic medical conditions
Diabetes mellitus 309 (5.9)
Hypertension 557 (10.7)
Heart disease 125 (2.4)
Stroke 32 (0.6)
Lung diseases‡ 278 (5.3)
Cancer 35 (0.7)
Musculoskeletal illnesses‡ 1,389 (26.6)
Mental illness‡ 136 (2.6)
Prevalence of co-existing chronic medical conditions in people with diabetes mellitus
Hypertension 115 (37.2)
Heart disease 46 (14.9)
Lung diseases‡ 27 (8.7)
Musculoskeletal illnesses‡ 107 (34.6)
Mental illnesses‡ 9 (2.9)
Mean (SD) Family Functioning Measure scores 10.3 (2.75)
Mean (SD) SF-36 scores†
Physical functioning (PF) 80.3 (23.19)
Role-physical (RP) 80.5 (32.94)
Bodily pain (BP) 78.3 (21.73)
General health (GH) 68.6 (17.21)
Vitality (VT) 63.8 (16.98)
Social functioning (SF) 80.6 (20.48)
Role-emotional (RE) 79.2 (34.98)
Mental health (MH) 72.4 (16.70)
Mean (SD) SF-6D index scores† 0.77 (0.130)
* Acute medical conditions were self-limiting illnesses and injuries in the preceding one month that might influence SF-36 scores and included acute 
illnesses (e.g. upper respiratory tract infections, gastroenteritis and headaches), injuries or poor sleep. † Mean scores adjusted for the influence of 
diabetes mellitus, other chronic medical conditions (and their interactions), socioeconomic status and other factors. ‡ Lung diseases included asthma 
and other lung diseases; musculoskeletal illnesses included rheumatism, back pain and other bone or muscle illness; mental illness included 
depression, anxiety disorder and schizophrenia.
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that the influence of two chronic medical conditions on
HRQoL scores was additive. The presence of a significant
interaction term would suggest that a synergistic or sub-
tractive relationship existed, the former if the coefficient
for the interaction term was negative, the latter if the coef-
ficient was positive (since changes in HRQoL scores in the
presence of chronic medical conditions were expected to
be negative). Ethnicity was coded using dummy variables.
Educational level was used as proxy for socioeconomic
status. In anticipation that if the number of subjects with
a given chronic medical condition was less than 50, the
numbers of subjects with this medical condition and dia-
betes would be very small and not amenable to meaning-
ful interpretation, two chronic medical conditions, stroke
and cancer, were thus excluded from analysis because of
small numbers of subjects reporting these conditions
(n<50). Two other chronic medical conditions were sub-
sequently excluded from analysis because of small num-
bers of subjects with diabetes and these conditions
(diabetes and lung diseases: n = 27 and diabetes and men-
tal illnesses: n = 9).
Results
Characteristics of study subjects
Complete data were available from 5,224 of 5,420 sub-
jects in the study, with 196 (3.6%) subjects excluded from
analysis (110 because of missing demographic informa-
tion and 86 because of missing responses to the SF-36).
Table 1 shows subjects' characteristics and distribution of
SF-36 scales and SF-6D index scores. Approximately 6% of
subjects suffered from diabetes and two-fifths of subjects
reported at least 1 chronic medical condition. Prevalence
of co-existing conditions in subjects with diabetes ranged
from 2.9% (mental illnesses) to 37.2% (hypertension).
Table 2: Influence of diabetes mellitus and other chronic medical conditions on SF-36 scales.
Unadjusted differences in mean scores
PF RP BP GH VT SF RE MH SF-6D
No chronic medical condition† 
(n = 3155)
82.0 
(22.61)
81.9 
(32.16)
80.4 
(21.20)
70.0 
(16.62)
64.8 
(16.43)
81.5 
(20.12)
77.5 
(36.00)
73.1 
(16.35)
0.79 
(0.123)
Diabetes mellitus only (n = 309) -7.2 -7.3 -5.8 -3.5 -1.3 -1.8 0.7 0.2 -0.06
Hypertension only 
(n = 557)
-4.3 -4.1 -3.4 -3.3 -0.5 0.5 1.0 0.3 -0.05
Heart disease only (n = 125) -9.5 -10.1 -7.3 -5.2 -3.6 -0.8 -4.7 -0.3 -0.09
Musculoskeletal illnesses only‡ 
(n = 1389)
-4.7 -3.6 -6.9 -4.4 -3.1 -2.7 -0.8 -2.5 -0.08
Adjusted differences in mean scores due to medical condition§
PF RP BP GH VT SF RE MH SF-6D
No chronic medical condition† 
(n = 3155)
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.00
Diabetes mellitus only (n = 309) -2.9 * -3.7 -1.8 -2.36 * -1.3 -0.1 0.3 -0.2 -0.03 **
Hypertension only 
(n = 557)
-2.6 * -3.1 * -1.5 -1.6 0.1 0.6 -1.0 0.1 -0.03 ***
Heart disease only (n = 125) -5.0 * -6.5 * -3.5 -4.0 * -3.9 * 0.9 -5.9 -1.0 -0.06 ***
Musculoskeletal illnesses only‡ 
(n = 1389)
-3.8
***
-3.1
**
-6.4
***
-3.9
***
-2.9
***
-3.1
***
-3.4
**
-2.6
***
-0.08
***
†Mean (SD) scores
‡Musculoskeletal illnesses included rheumatism, back pain and other bone or muscle illnesses.
§Multiple linear regression, adjusted for influence of ethnicity, age, gender and years of education.
*p < 0.05, **p < 0.01, ***p < 0.001
Abbreviations: PF = Physical Functioning, RP = Role-Physical, BP = Bodily Pain, GH = General Health, VT = Vitality, SF = Social Functioning, RE = 
Role -Emotional, MH = Mental Health
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The influence of chronic medical conditions on SF-36 
scores
The influence of chronic medical conditions on individ-
ual SF-36 scales is presented in Table 2. Before adjusting
for selected sociodemographic variables known to influ-
ence HRQoL (i.e. age, gender, ethnicity and years of edu-
cation), subjects with self-reported chronic medical
conditions (diabetes, hypertension, heart disease and
musculoskeletal illnesses) generally reported lower scores
for most SF-36 scales when compared to subjects without
these conditions, indicating poorer HRQoL. After adjust-
ing for the influence of these sociodemographic variables,
chronic medical conditions continued to influence
HRQoL, generally to a lesser degree than before adjust-
ment. The influences of heart disease and musculoskeletal
illnesses on SF-36 scores were of a similar magnitude and
were larger than the influence of diabetes or hypertension.
The influence of chronic medical conditions on SF-6D 
scores
The influence of chronic medical conditions on SF-6D
scores is also presented in Table 2. Subjects with chronic
medical conditions similarly reported lower unadjusted
mean SF-6D scores. After adjusting for known determi-
nants of HRQoL, lowering of SF-6D scores persisted for all
chronic medical conditions, though again to a smaller
magnitude. The influences of heart disease and muscu-
loskeletal illnesses on SF-6D scores were of a similar mag-
nitude and were again larger than the influence of
diabetes or hypertension.
The influence of diabetes mellitus and co-existing chronic 
medical conditions on SF-36 scores
Characteristics of subjects with diabetes, with and without
other co-existing chronic medical conditions, are shown
in Table 3. Subjects with diabetes only (i.e. no co-existing
chronic medical conditions) were generally younger and
more likely to be male. There were more Indians with dia-
betes and co-existing heart disease or musculoskeletal
illnesses and more Chinese with diabetes and co-existing
hypertension. The distribution of years of education com-
pleted was fairly similar in the various ethnic groups.
The impact of co-existing chronic medical conditions on
adjusted SF-36 scores of subjects with diabetes is pre-
sented in Table 4. In general, after adjusting for known
determinants of HRQoL, the presence of concurrent
hypertension, heart disease and musculoskeletal illnesses
further reduced SF-36 scores in subjects with diabetes. For
example, subjects with diabetes and co-existing hyperten-
sion or musculoskeletal illnesses experienced further low-
ering of physical functioning scores by 2.3 and 3.7 points,
respectively. The influence of two chronic medical condi-
tions on SF-36 scores was generally additive, in that statis-
tically significant interaction terms were not present for
most comparisons. There were some exceptions in which
subtractive effects were observed, mainly clustered within
subjects with diabetes and co-existing heart disease (phys-
ical functioning, role-physical, social functioning and
role-emotional scales) or musculoskeletal illnesses (bod-
ily pain and social functioning scales).
Table 3: Characteristics of subjects with diabetes, with and without other chronic medical conditions.
Co-existing chronic medical conditions among subjects with diabetes
Characteristics No co-existing chronic medical 
conditions
(n = 115)
Hypertension
(n = 115)
Heart disease
(n = 46)
Musculoskeletal illnesses† 
(n = 107)
Mean age (years) 48.1 (10.52) 53.7 (8.46) 55.5 (7.95) 53.2 (8.68)
Male (%) 64.3 56.5 71.7 54.2
Ethnicity (%)
Chinese 23.5 40.0 21.7 36.4
Malays 27.8 22.6 21.7 17.8
Indians 48.7 37.4 56.5 45.8
Questionnaire language (English) (%) 86.1 73.9 91.3 76.6
Education (%)
≤ 6 years 36.5 44.3 30.4 41.1
7–10 years 50.4 42.6 56.5 48.6
> 10 years 13.0 13.0 13.0 10.3
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Table 4: Multiple linear regression models of the influence of diabetes mellitus and a second chronic medical condition (i.e. 
hypertension, heart disease or musculoskeletal illnesses) adjusted for ethnicity, age, gender and years of education on SF-36 and SF-6D 
scores.
Co-existing chronic medical conditions among subjects with diabetes
No co-existing chronic 
medical conditions
(n = 115)
Hypertension
(n = 115)
Heart disease 
(n = 46)
Musculoskeletal 
illnesses† 
(n = 107)
Physical Functioning
Differences in scale scores due to
Diabetes mellitus -2.9* -2.4 -3.5* -2.8*
2nd chronic medical condition‡ na -2.3* -7.9** -3.7***
Interaction termξ na ns 12.46** ns
Role-Physical
Differences in scale scores due to
Diabetes mellitus -3.7 -3.1 -5.2* -3.6
2nd chronic medical condition‡ na -2.8 -12.5** -3.1**
Interaction termξ na ns 20.1** ns
Bodily Pain
Differences in scale scores due to
Diabetes mellitus -1.8 -1.6 -1.5 -3.8*
2nd chronic medical condition‡ na -1.3 -3.1 -6.9***
Interaction termξ na ns ns 7.0**
General Health
Differences in scale scores due to
Diabetes mellitus -2.3* -2.0 -1.9 -2.2*
2nd chronic medical condition na -1.3 -3.5* -3.9***
Interaction termξ na ns ns ns
Vitality
Differences in scale scores due to
Diabetes mellitus -1.3 -1.4 -0.9 -1.3
2nd chronic medical condition‡ na 0.3 -3.7* -2.9***
Interaction termξ na ns ns ns
Social Functioning
Differences in scale scores due to
Diabetes mellitus -0.1 -0.2 -1.3 -1.9
2nd chronic medical condition‡ na 0.6 -2.5 -3.4***
Interaction termξ na ns 10.2* 5.4*
Role-Emotional
Differences in scale scores due to
Diabetes mellitus 0.3 -2.8 -0.9 0.4
2nd chronic medical condition‡ na -2.7 -11.8** -3.4**
Interaction termξ na 9.9* 16.8* ns
Mental Health
Differences in scale scores due to
Diabetes mellitus -0.2 -1.7 -0.1 -0.1
2nd chronic medical condition‡ na -0.5 -0.9 -2.6***
Interaction termξ na 5.1* ns ns
SF-6D
Differences in scale scores due to
Diabetes mellitus -0.03** -0.02* -0.02* -0.02**
2nd chronic medical condition‡ na -0.03*** -0.06*** -0.08***
Interaction termξ na ns ns ns
†Musculoskeletal illnesses included rheumatism, back pain and other bone or muscle illnesses.
‡Second chronic medical condition refers to the chronic medical condition other than diabetes mellitus listed in the relevant column (e.g. 
hypertension, heart disease or musculoskeletal illnesses).
ξ Interaction term for diabetes mellitus and second chronic medical condition.
*p < 0.05, **p < 0.01, ***p < 0.001, ns denotes statistically insignificant.
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The influence of diabetes mellitus and co-existing chronic 
medical conditions on SF-6D scores
The influence of diabetes and co-existing chronic medical
conditions on SF-6D scores is presented in Table 4. Sub-
jects with diabetes and other co-existing chronic medical
conditions reported lower unadjusted SF-6D scores than
subjects with diabetes only. After adjustment for known
determinants of HRQoL, the influence of co-existing
chronic medical conditions on SF-6D scores persisted. As
before, subjects with diabetes and co-existing heart dis-
ease or musculoskeletal illnesses reported the greatest
impairment in HRQoL. Diabetes and other co-existing
chronic medical conditions, including heart disease,
reduced SF-6D scores in an additive fashion.
Discussion
In this multiethnic, population-based study, we found
that subjects with diabetes experienced lowering of
HRQoL as compared to subjects without diabetes. The
presence of other chronic medical conditions in subjects
with diabetes led to further lowering of HRQoL, the effect
of which was generally additive. Our findings further
underscore the importance of preventing and treating
complications of diabetes to prevent further deterioration
in HRQoL among subjects with diabetes, and also high-
light the need to identify factors that may be modulated
to improve HRQoL in these subjects.
Our findings are important for several reasons. First, this
is the first study showing that the combination of diabetes
and a second chronic medical condition may adversely
affect the mental domains of HRQoL as measured by the
vitality, social functioning and mental health scales of the
SF-36 (previous studies having focused on the physical
domains of HRQoL) [23,24]. Second, it is reassuring that
the effect of diabetes and a second chronic medical condi-
tion on HRQoL was in general additive rather than syner-
gistic. Third, given that subjects were drawn from the
general population, it is likely that our findings can be
readily generalized to the population at large, especially
given that this study was conducted in a multiethnic Asian
population with one of the highest diabetes prevalence
rates in the world [35].
We found that the effect of diabetes on HRQoL was gen-
erally mild, with greater impact on the SF-36 scales meas-
uring physical (physical functioning, role-physical, bodily
pain, general health, role-emotional (in this study sam-
ple)) relative to mental health components (vitality,
social functioning and mental health). This was not sur-
prising, given that our subjects were recruited from the
general population and were therefore likely to have less
severe illness than subjects in hospital or clinic-based
studies. Further, other studies have shown that impact of
diabetes on HRQoL is intermediate, relative to other
chronic medical conditions [14]. For example, Egede [9]
reported that the risk of functional disability was lower in
subjects with diabetes than subjects with major depres-
sion (odds ratio (OR): 2.42 vs 3.00), while Otiniano et al.
[23] found that the risk of disabilities in ADL were lower
in subjects with diabetes than those with strokes (OR:
2.80 vs 5.55).
We also found that with the exception of subjects with
diabetes and heart disease, the presence of co-existing
chronic medical conditions in subjects with diabetes gen-
erally resulted in further significant lowering of HRQoL.
Our results are important because they demonstrate that
the impact of these co-existing chronic medical conditions
in diabetes is not only in increasing healthcare costs
[36,37] and mortality [38] but also in increasing the phys-
ical and psychosocial burden of diabetes. Given that com-
plications of diabetes constitute the majority of chronic
medical conditions commonly present in subjects with
diabetes, our findings further underscore the importance
of preventing and treating complications of diabetes, and
also highlight the need to identify factors that may be
modulated to improve HRQoL in these subjects.
In our study, the relationships between diabetes and other
chronic medical conditions on HRQoL were largely addi-
tive. This is in contrast with the study by Gaynes et al. [19],
where synergistic effects between depression and diabetes
on HRQoL were observed. Instead, we found in general an
additive effect with several comparisons showing a sub-
tractive effect on HRQoL (especially in subjects with dia-
betes and co-existing heart disease). There are several
possible explanations for the presence of subtractive
effects. One possible explanation is the presence of
response shift related to the specific diseases involved. In
this study, the subtractive effects were clustered among
subjects with diabetes and co-existing heart disease. Dia-
betes (in particular Type 2 diabetes) is a well-recognized
cardiovascular risk factor with subjects with diabetes com-
monly developing heart disease in the 5th or 6th decade of
life [40], often many years after the diagnosis of diabetes
[41] (although heart disease may on occasion be present
at or before diagnosis) [42,43]. In contrast, hypertension
typically precedes or occurs soon after diagnosis in sub-
jects with Type 2 diabetes, with up to 50% of subjects with
diabetes presenting with hypertension at the time of diag-
nosis [44]. Hence, adaptation to the underlying diabetes
may have led to response shift occurring in subjects with
diabetes and co-existing heart disease but not with hyper-
tension. A second plausible explanation for this observa-
tion is a healthy-responder effect. This would occur if
subjects with diabetes and co-existing heart disease were
more likely to have passed away or were too sick to partic-
ipate in the study. Thus the subset of subjects with diabe-
tes and co-existing heart disease who did participate in
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this study would reflect the healthier end of the spectrum,
leading to the observed effect of higher scores for respond-
ents with the two co-existing chronic medical conditions.
A third possible explanation is that some conditions are
so similar in their effects on HRQoL that having more
than one such condition is not particularly problematic to
the individual. For example, in our study, subjects with
diabetes alone and subjects with heart disease alone expe-
rienced lower scores on the physical functioning scale of
the SF-36; if these two conditions exerted a similar effect
on HRQoL, then a subtractive effect would be expected, as
was indeed observed among subjects with diabetes and
co-existing heart disease.
A secondary objective of this study was to understand the
extent to which the single index SF-6D captured informa-
tion from the multidimensional SF-36. We found that in
general, the impact of co-existing chronic medical condi-
tions on the SF-36 was well-reflected in the SF-6D. How-
ever, the subtractive effects of diabetes and co-existing
heart disease on SF-36 scores were not reflected in SF-6D
scores. This suggests that there is some inevitable loss of
information associated with a reduction from a multi-
dimensional scale to a unidimensional scale. Hence, more
studies are needed to evaluate the adequacy of the SF-6D
as a summary measure of the SF-36.
We recognize several limitations of this study. First, iden-
tification of chronic medical conditions was based on self-
report which may not be as accurate as physician diag-
noses. However, reliability of self-report has been found
to be acceptable for conditions that required medical or
laboratory diagnostic procedures, including diabetes [45-
47]. Second, although we captured information on sub-
jects with diabetes and co-existing mental illnesses or lung
diseases, we had to exclude these because of the small
number of subjects. Finally, in this study we did not dif-
ferentiate between subjects with Type 1 and Type 2 diabe-
tes. However, given that more than 90% of subjects with
diabetes are Type 2, this is not likely to affect our findings.
Conclusions
In conclusion, in this large, multiethnic, population-
based study, we found that subjects with diabetes experi-
enced lowering of HRQoL as compared to subjects with-
out diabetes. The co-existence of other chronic medical
conditions in subjects with diabetes led to further lower-
ing of HRQoL, the effect of which was generally additive.
Finally, we found that the SF-6D is a reasonably good
summary measure of the SF-36 although more studies are
needed to confirm this observation.
List of abbreviations
ADL – Activities of Daily Living, DM – Diabetes mellitus,
HD – Heart disease, HRQoL – Health-related quality of
life, HTN – Hypertension, MS – Musculoskeletal illnesses,
OR – Odds ratio, SF-36 – Medical Outcomes Short-Form
36.
Authors' contributions
JT conceived of the study, and participated in its design
and coordination. HL Wee and YB Cheung participated in
the design of the study and performed the statistical anal-
ysis. SC Li and KY Fong participated in the design of the
study and its coordination. All authors read and approved
the final manuscript.
Acknowledgements
We would like to thank Dr John Brazier for providing the scoring algorithm 
for the SF-6D, and Prof PH Feng, Drs ML Boey, KH Leong and Staff Nurse 
ST Thio for their contributions to the study on which this analysis is based.
This study was funded by grants from the Biomedical Research Council of 
Singapore (03/1/27/18/226) and the National Medical Research Council of 
Singapore (0160/96).
References
1. Gu K, Cowie CC, Harris MI: Mortality in adults with and without
diabetes in a national cohort of the U.S. population, 1971–
1993. Diabetes Care 1998, 21:1138-1145.
2. Diabetes Atlas 2000. International Diabetes Federation, Brussels 2000.
3. Eaton WW: Epidemiologic evidence on the comorbidity of
depression and diabetes. J Psychosom Res 2002, 53:903-906.
4. Dodson PM: Hypertension and diabetes. Curr Med Res Opin 2002,
18:s48-s57.
5. Maggio CA, Pi-Sunyer FX: Obesity and type 2 diabetes. Endocrinol
Metab Clin North Am 2003, 32:805-822. viii
6. Kannel WB, McGee DL: Diabetes and cardiovascular disease.
The Framingham study. JAMA 1979, 241:2035-2038.
7. Wingard DL, Barrett-Connor E: Heart disease and diabetes. In
Diabetes in America 2nd edition. NIH Pub. No. 95–1468. National Dia-
betes Data Group. National Institute of Health, National Institute of
Diabetes and Digestive and Kidney Disease. Bethesda, MD;
1995:429-434. 
8. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ: The prevalence
of comorbid depression in adults with diabetes: a meta-anal-
ysis. Diabetes Care 2001, 24:1069-1078.
9. Egede LE: Diabetes, major depression, and functional disabil-
ity among U.S. adults. Diabetes Care 2004, 27:421-428.
10. Reddy SS: Health outcomes in type 2 diabetes. Int J Clin Pract
Suppl 2000, 113:46-53.
11. Harris MI: Health care and health status and outcomes for
patients with type 2 diabetes. Diabetes Care 2000, 23:754-758.
12. Hornquist JO, Wikby A, Stenstrom U, Andersson PO, Akerlind I:
Type II diabetes and quality of life: a review of the literature.
Pharmacoeconomics 1995, 8(Suppl 1):12-16.
13. Stewart AL, Greenfield S, Hays RD, Wells K, Rogers WH, Berry SD,
McGlynn EA, Ware JE Jr: Functional status and well-being of
patients with chronic conditions. Results from the Medical
Outcomes Study. JAMA 1989, 262(7):907-913.
14. Alonso J, Ferrer M, Gandek B, Ware JE Jr, Aaronson NK, Mosconi P,
Rasmussen NK, Bullinger M, Fukuhara S, Kaasa S, Leplege A, IQOLA
Project Group: Health-related quality of life associated with
chronic conditions in eight countries: results from the Inter-
national Quality of Life Assessment (IQOLA) Project. Qual
Life Res 2004, 13:283-298.
15. Sprangers MA, de Regt EB, Andries F, van Agt HM, Bijl RV, de Boer
JB, Foets M, Hoeymans N, Jacobs AE, Kempen GI, Miedema HS,
Tijhuis MA, de Haes HC: Which chronic conditions are associ-
ated with better or poorer quality of life? J Clin Epidemiol 2000,
53:895-907.
16. de Visser CL, Bibo HJ, Groenier KH, de Visser W, Jong Meyboom-de
B: The influence of cardiovascular disease on quality of life in
type 2 diabetics. Qual Life Res 2002, 11:249-261.
Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Health and Quality of Life Outcomes 2005, 3:2 http://www.hqlo.com/content/3/1/2
Page 11 of 11
(page number not for citation purposes)
17. Lloyd A, Sawyer W, Hopkinson P: Impact of long-term complica-
tions on quality of life in patients with type 2 diabetes not
using insulin. Value Health 2001, 4:392-400.
18. Ware JE, Kosinski M, Keller SD: SF-36 physical and mental
health summary scales: A user's manual. New England Medical
Center, the Health Institute, Boston; 1994. 
19. Gaynes BN, Burns BJ, Tweed DL, Erickson P: Depression and
health-related quality of life. J Nerv Ment Dis 2002, 190:799-806.
20. Evans DL, Staab J, Ward H, Leserman J, Perkins DO, Golden RN,
Petitto JM: Depression in the medically ill: management
considerations. Depress Anxiety 1996, 4:199-208.
21. Zellweger MJ, Osterwalder RH, Langewitz W, Pfisterer ME: Coro-
nary artery disease and depression. Eur Heart J 2004, 25:3-9.
22. Sprangers MA, Schwartz CE: Integrating response shift into
health-related quality of life research: a theoretical model.
Soc Sci Med 1999, 48:1507-1515.
23. Otiniano ME, Du XL, Ottenbacher K, Markides KS: The effect of
diabetes combined with stroke on disability, self-rated
health, and mortality in older Mexican Americans: results
from the Hispanic EPESE. Arch Phys Med Rehabil 2003,
84:725-730.
24. Oldridge NB, Stump TE, Nothwehr FK, Clark DO: Prevalence and
outcomes of comorbid metabolic and cardiovascular condi-
tions in middle- and older-age adults. J Clin Epidemiol 2001,
54:928-934.
25. Thumboo J, Fong KY, Machin D, Chan SP, Leong KH, Feng PH, Thio
ST, Boey ML: A community-based study of scaling assump-
tions and construct validity of the English (UK) and Chinese
(HK) SF-36 in Singapore. Qual Life Res 2001, 10:175-188.
26. Cheung P, ed: Singapore Census of Population 1990. Singapore:
Department of Statistics 1992.
27. McHorney CA, Ware JE Jr, Raczek AE: The MOS 36-Item Short-
Form Health Survey (SF-36): II. Psychometric and clinical
tests of validity in measuring physical and mental health
constructs. Med Care 1993, 31:247-263.
28. Lam CL, Gandek B, Ren XS, Chan MS: Tests of scaling assump-
tions and construct validity of the Chinese (HK) version of
the SF-36 health survey. J Clin Epidemiol 1998, 51:925-932.
29. Brazier J, Roberts J, Deverill M: The estimation of a preference-
based measure of health from the SF-36. J Health Econ 2002,
21:271-292.
30. Brazier J, Usherwood T, Harper R, Thomas K: Deriving a prefer-
ence-based single index from the UK SF-36 Health Survey. J
Clin Epidemiol 1998, 51:1115-1128.
31. Sherbourne CD, Kamberg CJ: Social functioning: Family and
marital functioning measures. In Measuring functioning and well-
being: The medical outcomes study approach Edited by: Stewart AL,
Ware JE. Durham: Duke University Press; 1992:183-193. 
32. Thumboo J, Fong KY, Chan SP, Leong KH, Feng PH, Thio ST, Boey
ML: Validation of the medical outcomes study family and
marital functioning measures in SLE patients in Singapore.
Lupus 1999, 8:514-520.
33. Thumboo J, Fong KY, Chan SP, Machin D, Feng PH, Thio ST, Boey ML:
The equivalence of English and Chinese SF-36 versions in
bilingual Singapore Chinese. Qual Life Res 2002, 11(5):495-503.
34. Wee HL, Cheung YB, Fong KY, Luo N, Machin D, Thumboo J: Are
English and Chinese SF-6D versions equivalent? A compari-
son from a population-based study. Clin Therp 2004,
26:1137-1148.
35. International Diabetes Federation: Prevalence estimates of dia-
betes mellitus in Western Pacific region.  [http://www.idf.org/
e-atlas/home/index.cfm?node=104].
36. O'Brien JA, Patrick AR, Caro JJ: Cost of managing complications
resulting from type 2 diabetes mellitus in Canada. BMC Health
Serv Res 2003, 3:7.
37. Brown JB, Pedula KL, Bakst AW: The progressive cost of compli-
cations in type 2 diabetes mellitus. Arch Intern Med 1999,
159:1873-1880.
38. Wang SL, Head J, Stevens L, Fuller JH: Excess mortality and its
relation to hypertension and proteinuria in diabetic patients.
The World Health Organization multinational study of vas-
cular disease in diabetes. Diabetes Care 1996, 19:305-312.
39. Patrick DL, Deyo RA: Generic and disease-specific measures in
assessing health status and quality of life. Med Care 1989,
27:S217-S232.
40. American Diabetes Association: Consensus development confer-
ence on the diagnosis of coronary heart disease in people
with diabetes (Consensus Statement). Diabetes Care 1998,
21:1551-1559.
41. Stevens RJ, Kothari V, Adler AI, Stratton IM, United Kingdom Pro-
spective Diabetes Study (UKPDS) Group: The UKPDS risk
engine: a model for the risk of coronary heart disease in
Type II diabetes (UKPDS 56). Clin Sci (Lond) 2001, 101:671-679.
42. Garber AJ: Vascular disease and lipids in diabetes. Med Clin
North Am 1998, 82:931-948.
43. Erkens JA, Herings RM, Stolk RP, Spoelstra JA, Grobbee DE, Leufkens
HG: Cardiovascular risk factors and diseases precede oral
hypoglycaemic therapy in patients with type 2 diabetes
mellitus. J Clin Epidemiol 2002, 55:345-349.
44. Brownlee M, Aiello LP, Friedman E, Vinik AI, Nesto RW, Boulton
AJM: Complications of diabetes mellitus. In Williams Textbook of
Endocrinology 10th edition. Philadelphia: WB Saunders;
2002:1509-1560. 
45. Harlow SD, Linet MS: Agreement between questionnaire data
and medical records. The evidence for accuracy of recall. Am
J Epidemiol 1989, 129:233-248.
46. Midthjell K, Holmen J, Bjorndal A, Lund-Larsen G: Is questionnaire
information valid in the study of a chronic disease such as
diabetes? The Nord-Trondelag diabetes study. J Epidemiol Com-
munity Health 1992, 46:537-542.
47. Tretli S, Lund-Larsen PG, Foss OP: Reliability of questionnaire
information on cardiovascular disease and diabetes: cardio-
vascular disease study in Finnmark county. J Epidemiol Commu-
nity Health 1982, 36:269-273.
